Data protection Impressum

Investment

EssilorLuxottica’s acquisition of RetinAI strengthens its medtech portfolio with advanced AI and data-driven solutions for eye disease management.

EssilorLuxottica acquires Bern-based RetinAI to accelerate AI-powered eye health innovation

20 October 2025

A consortium of academic, industrial, and public actors launches Geneva’s first quantum network to advance secure communication and precision technologies.

Geneva launches its first quantum communication network

15 October 2025

UCB is investing more than CHF 100 million in its Bulle site to boost capacity, create new jobs, and strengthen sustainable production.

UCB invests over CHF 100 million to expand its biopharmaceutical site in Bulle

7 October 2025

Nestlé has reinforced its global expertise in child nutrition with the inauguration of a state-of-the-art quality laboratory at its Konolfingen site in the canton of Bern. The CHF 17.5 million investment, which created six new jobs, is the latest in a decade-long modernization effort that has seen nearly CHF 150 million invested at the site.

Nestlé strengthens child nutrition hub in Konolfingen with new quality laboratory

30 September 2025

Top Stories Western Switzerland

Top Stories from Western Switzerland (September 2025)

30 September 2025

French robotics company Meanwhile has chosen Fribourg for its first international subsidiary, strengthening its presence in Switzerland and reinforcing its capacity to serve clients across the country.

Meanwhile opens its first international subsidiary in Fribourg

22 September 2025

Top Stories Western Switzerland

Top Stories from Western Switzerland (July 2025)

4 August 2025

Neuchâtel, renowned globally for its watchmaking heritage, has evolved into a dynamic hub of cutting-edge innovation. Today, the canton leverages its tradition of precision craftsmanship to excel in fields as diverse as blockchain, quantum technology, renewable energy, life sciences, and advanced manufacturing. The canton of Neuchâtel’s transformation highlights its unique ability to merge historical excellence with visionary innovation, positioning itself as a leading force within Switzerland’s economic landscape.

Neuchâtel, a legacy of precision driving tomorrow’s innovation

Geneva-based biotech Stalicla secures funding to advance precision medicine programs for autism and substance use disorders.

Addex Therapeutics leads CHF 2 million investment in Stalicla

14 July 2025

Neuchâtel opens a blockchain-focused coworking space to support innovation, collaboration, and digital adoption in the region.

Neuchâtel strengthens its position as a blockchain hub with new coworking space

7 July 2025

1 2 3 4 5 … 20